Pelican Cancer Foundation

Pelican Cancer Foundation

  • Facebook
  • Instagram
  • Twitter
  • YouTube
DONATE NOW
  • Home
  • About Us
    • What we do
      • Bowel cancer
      • Colorectal Liver Metastases
      • Prostate cancer
      • Bladder cancer
      • Pseudomyxoma peritonei
      • Our Research
      • Our achievements
      • Media
    • Who we are
      • Our board
      • Our team
      • Pelican Patrons
    • Our annual accounts
    • Pelican Cancer Foundation – What next?
    • Support Us
    • Job opportunities
    • Partners
  • Workshops
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • What clinicians say about our courses
    • Faculty
    • Our sponsors
    • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Research
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Prostate Cancer Research
      • Focal therapy and HIFU research
      • MRI research for prostate cancer
      • Prostate cancer colloquiums
      • FORECAST
      • Trachtomap
      • Papers of interest
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Bladder cancer research
      • PELT
      • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for researchers
      • Peer review process
      • Research review panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Jay’s story (bladder cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Prostate cancer
      • Our prostate cancer team
      • Prostate cancer treatment options
      • Pelican’s position
    • Bladder cancer
      • Blue light cystoscopy
      • Bladder cancer – useful contacts
    • Pseudomyxoma peritonei
    • Kidney cancer
      • Our kidney cancer team
      • Kidney cancer – useful contacts
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Why donate to Pelican?
      • Donate shares
      • Donate in memory
      • How your donations are spent
    • Fundraising
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
      • Our events
    • Leaving a Legacy
    • Volunteering Opportunities
    • Could you host a Pelican Talk?
    • Charity of the Year partnerships
    • Pelican Film Society
  • Online Shop
  • Events
  • Contact us

Charity of the Year partnerships

Charity of the Year partners work with Pelican Cancer Foundation to raise money for the Charity and to make more people aware of the fantastic work that the charity does for cancer patients within the community and across the country.

Whether it is running marathons or fun runs, climbing mountains, holding an Elvis evening, baking cakes or running a quiz night the key is to working together and having fun.Making Pelican your Charity of the Year can encourage team building, boost staff morale and demonstrate your company values. Some companies engage their staff with their chosen charity by offering pro-bono professional support. We are a very small team and are always delighted to encourage this type of engagement.

If you are interested in choosing Pelican Cancer Foundation as your Charity of the Year, please contact us on 01256 314746.

Current Charity of the Year partners:

 

A-Plan Insurance 

A-Plan Insurance provides car, van, home & business insurance and prides itself in being Basingstoke’s local insurance expert. Find out more about them here.

Phillips Solicitors – Basingstoke

 

 

 

MRSL Enterprise – Basingstoke

 

Founded by a former Head of Operations of the NHS Litigation Authority and a PhD Engineer, MRSL focusses on insurances for medical risks. The core of their business is to work with medical businesses – surgeons, doctors, dentists and ancillary healthcare to understand their risks, and to develop products and accurate pricing to completely indemnify and insure these businesses.

MRSL Enterprise is also committed to obtaining fair insurance for those who wish to travel with medical conditions, including cancer. MRSL Enterprise will make a donation to Pelican for any policies taken out with them over the next 12 months. (commencing October 2018)

We are really excited to be partnering with MRSL Enterprise as their charity of the year!

World Doodle Day

Doodling has many great mental health benefits. World Doodle Day is an organisation that promotes the benefits of doodling in a corporate and personal setting by both holding a special doodle day, as well as other doodling activates throughout the year raising money for charities. This year, World Doodle Day has chosen Pelican Cancer Foundation as their charity of the year.

Pelican Cancer FoundationFollow

Pelican Cancer Foundation
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
6h

#BowelCancerAwarenessMonth #PelicanCancerFoundation

Reply on Twitter 1382936796049272833Retweet on Twitter 13829367960492728331Like on Twitter 13829367960492728331Twitter 1382936796049272833
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
15 Apr

#BowelCancerAwarenessMonth #PelicanCancerFoundation

Reply on Twitter 1382574408661864450Retweet on Twitter 13825744086618644503Like on Twitter 13825744086618644502Twitter 1382574408661864450
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
14 Apr

#BowelCancerAwarenessMonth #PelicanCancerFoundation

Reply on Twitter 1382212019726680067Retweet on Twitter 13822120197266800671Like on Twitter 13822120197266800671Twitter 1382212019726680067
Load More...

To view our privacy policy - click here.
Registered charity no: 1141911

Copyright © 2021 · Outreach Pro Theme on Genesis Framework · WordPress · Log in